Beijing Tiantan Biological Products (SHSE:600161) Institutional Ownership: 6.49% (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600161 Beijing Tiantan Biological Products Corp Ltd SHSE:600161
69 GF Score
Price ¥12.54
GF Value ¥22.84
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tiantan Biological Products Institutional Ownership?

Beijing Tiantan Biological Products SHSE:600161 -1.80% 69 Institutional Ownership is 6.49% as of Aug. 16, 2026. GuruFocus rates SHSE:600161 with a GF Score™ of 69/100 and a GF Value™ of ¥22.84 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Beijing Tiantan Biological Products's institutional ownership is 6.49%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Beijing Tiantan Biological Products's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Beijing Tiantan Biological Products's Float Percentage Of Total Shares Outstanding is 0.00%.

Beijing Tiantan Biological Products Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Beijing Tiantan Biological Products's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tiantan Biological Products Institutional Ownership Chart

Beijing Tiantan Biological Products Historical Data

The historical data trend for Beijing Tiantan Biological Products can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 9.04 9.01 7.01 6.98 6.65 6.54 6.54 6.53 6.49 6.49
SHSE:600161
69GF Score
Beijing Tiantan Biological Products Corp Ltd SHSE:600161
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tiantan Biological Products Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 6.49% mean?
Beijing Tiantan Biological Products (SHSE:600161) has a Institutional Ownership of 6.49% as of Aug. 16, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Beijing Tiantan Biological Products and its competitors.
Is Beijing Tiantan Biological Products' Institutional Ownership too high?
Beijing Tiantan Biological Products' current Institutional Ownership is 6.49%. Overall, Beijing Tiantan Biological Products has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Institutional Ownership compare to VRTX and REGN?
Beijing Tiantan Biological Products' Institutional Ownership of 6.49% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Beijing Tiantan Biological Products and its competitors. Beijing Tiantan Biological Products's current Institutional Ownership is 6.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥22.84, compared to a current price of ¥12.54 — trading 45.1% below its estimated fair value. The current Institutional Ownership is 6.49%. Beijing Tiantan Biological Products' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Institutional Ownership is 6.49% as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued. The current stock price of ¥12.54 is trading 45.1% below its estimated GF Value™ of ¥22.84. GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.

Key valuation signals for SHSE:600161:

  • Institutional Ownership: 6.49%
  • GF Value™: ¥22.84 vs. price of ¥12.54 (45.1% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tiantan Biological Products Business Description

Address No. 2, Shuangqiao Road, Chaoyang District, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
69GF Score

Get the complete analysis for SHSE:600161

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.54
Price
¥22.84
GF Value